Isomorphic Labs has unveiled its Drug Design Engine (IsoDDE), a computational platform designed to advance drug discovery beyond the capabilities of AlphaFold. This new engine demonstrates superior accuracy in predicting protein and ligand structures, with over double the generalization ability for novel protein structures compared to AlphaFold 3. IsoDDE also excels in predicting antibody-antigen binding and molecular affinity, offering a faster, more cost-effective approach that promises to significantly shorten drug development timelines. AI
IMPACT Accelerates drug discovery by improving protein structure prediction and binding affinity assessment, potentially reducing development costs and timelines.
RANK_REASON Product launch from a notable AI-focused biotech company.
Read on Mastodon — sigmoid.social →
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →
